[Federal Register Volume 76, Number 21 (Tuesday, February 1, 2011)]
[Notices]
[Page 5595]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-2206]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Detection of Cancer Biomarkers on a Universal Nanoplatform.
    Date: March 24, 2011.
    Time: 12 p.m. to 2 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 706, Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Kenneth L. Bielat, PhD, Scientific Review 
Officer, Special Review Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7147, Bethesda, MD 20892-8329, 301-496-7576, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Glycosylation-Specific Research Reagents 
(Antibodies and Aptamers).
    Date: March 31, 2011.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Lorien Hotel & Spa, 1600 King Street, Alexandria, VA 
22314.
    Contact Person: Marvin L. Salin, PhD, Scientific Review Officer, 
Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-496-0694, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Clinical Automated Multiplex Affinity Capture 
Technology for Detecting Low Abundance Cancer-Related Proteins/
Peptides.
    Date: April 1, 2011.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Lorien Hotel & Spa, 1600 King Street, Alexandria, VA 
22314.
    Contact Person: Marvin L. Salin, PhD, Scientific Review Officer, 
Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-496-0694, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 25, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-2206 Filed 1-31-11; 8:45 am]
BILLING CODE 4140-01-P